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A complex mixture of isomeric neutral oligosaccharides from pooled human milk was
analyzed by nano-electrospray ionization (ESI) in a quadrupole ion trap mass spectrometer
(QIT-MS) in the negative ion mode. Since deprotonated molecules of neutral oligosaccharides
follow distinct fragmentation rules, which have been elucidated by using model compounds
(see [1]), spectra obtained from consecutive CID experiments allowed the differentiation of
isomers out of this highly complex mixture. With this method new human milk oligosaccha-
rides of previously unknown isomeric structures have been identified, e.g., the occurence of
three isomeric fucosylated lacto-N-hexaoses could be determined precisely, which have not
been described before: (1) Fuc (13 2) Gal (13 3) GlcNac (13 3) Gal (13 4) GlcNac
(13 3) Gal (13 4) Glc, (2) Gal (13 4) GlcNAc [(13 3) Fuc] (13 3) Gal (13 4)
GlcNac (13 3) Gal (13 4) Glc, (3) Gal (13 4) GlcNAc (13 3) Gal (13 4) GlcNac
[(13 3) Fuc] (13 3) Gal (13 4) Glc. (J Am Soc Mass Spectrom 2002, 13, 1341–1348) ©
2002 American Society for Mass Spectrometry
Over the past decades, glycosylation of specificmolecular structures or cell surfaces have beenrecognized to play an important role in physi-
ology [2]. Also, free oligosaccharides, which are present
either extracellular or in cell matrices, are believed to
have other than nutritional function. As the (bio)chem-
ical basis of many life processes is known, both recog-
nition of diseases and the development of medical
treatment becomes possible. Also preventional health
treatment gains importance; especially nutrition is
known to be an essential factor. This leads to the
development of nutritional additives with healing and
precautional character (functional food).
As revealed by MALDI/MS human milk contains
neutral as well as acidic oligosaccharides of high mo-
lecular weight [3, 4], of which the biological function is
yet not known, but there is some evidence that these
compounds have essential biological functions [5, 6]. It
is hypothesized that due to their structural similarity to
the sugars in N-and O-glycans and their resistance
against digestion by glycosidases specific for N- and O-
glycans, human milk oligosaccharides are able to reach
the colon. There they may be potential, water-soluble
receptor analogues which prevent interactions of patho-
genic bacteria, viruses, fungi, or effects of toxins. They
also may have benificial effects for the development of
a specific intestinal flora of breast-fead infants. As they
are potential nonimmunological factors, human milk
oligosaccharides are under discussion as supplements
for infant formula. Therefore, knowledge of their spe-
cific biological activity and the crucial concentration is
necessary.
This demands analytical tools that provide structural
elucidation of bioactive compounds and their active
concentration. Today, there is no universal method for
the characterization of oligosaccharides. Traditional
methods for structural analysis of oligosaccharides are
time and cost consuming. Even though NMR spectros-
copy as well as X-ray crystallography have been suc-
cessfully applied [7, 8], both methods need high
amounts of sample in high purity. Mass spectrometry is
a useful and sensitive method to investigate samples of
low absolute amount and concentration or in complex
mixtures. The useful combination of classical enzymatic
approach and mass spectrometry is not only time
consuming and costly, it is also limited to samples, that
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contain pure compounds, i.e., structural analysis of
complex mixtures is not possible. Some mass spectrom-
eters provide the possibility to perform structure eluci-
dation studies such as triple-quadrupole [9], quadrople
ion trap [10, 11], or FTICR mass spectrometry [12],
based on collision-induced fragmentation (CID) or
MALDI-TOF-MS (post-source-decay analysis) [13, 14].
Therefore, single compounds from even complex mix-
tures can be selected and applied to MS/MS experi-
ments.
A strategy for structural analysis of underivatized,
neutral human milk oligosaccharides has been pre-
sented based on CID-MS/MS experiments in an quad-
rupole ion trap in the negative ion mode using a
nano-electrospray source (see [1]). Under these condi-
tions, neutral oligosaccharides can be investigated as
deprotonated molecules with high sensitivity [15, 16];
their fragmentation behavior has been elucidated based
on certain isomeric glycoforms yielding both complete
sequence and linkage information as well as fucose
position and branching sites. A summary of the ob-
served fragment ions for several test compounds is
given in Table 1.
These fragmentation rules are applied to oligosac-
charides, the complex total mixtures stemming from
GPC fractions of human milk oligosaccharides in order




The separation of oligosaccharides from pooled human
milk was performed as described in [4, 17–19]; in this
study, GPC subfractions of neutral oligosaccharides
were analyzed. For mass analysis the lyophilized GPC-
subfractions were dissolved in deionized water to a
total concentration of 1 g/L; ammonium acetate (103
M) was used as additive (3:1,vol:vol).
Instrumentation
For mass analysis and structure elucidation a quadru-
pole ion trap mass spectrometer was used (LCQ, Finni-
gan MAT, San Jose, CA) equipped with a nano-ESI
source (Protana, Odense, Denmark). The spray needles
used were laboratory-pulled, gold-coated glass capillar-
ies with an orifice diameter in the range of 1–2 m.
Typically 1–3 l of the sample solution were loaded.
The spray voltage was between 600–1200 V, the transfer
capillary was held at temperature of 200 °C. The LCQ
Table 1. Summary of observed fragment ions for test compounds
LNT LNnT LNpara LNFP I LNFP II LNFP III LNFP III LNDFH I LNDFH II LNH LNnH TFLNH
MS2 706 706 1071 852 852 852 852 998 998 1071 1071 1509
2 2 2 2 2 2 2 2 2 2 2 2
646 646 1011 792 792 792 688 938 834 1011 1011 1449
628 628 993 774 774 774 544 920 690 993 993 1431
544 544 909 690 690 690 382 836 528 909 909 1347
382 382 747 528 528 528 674 348 526 526 672
202 281 646 325 348 364 348 508 508 600
263 628 325 454 454
544 382 382
382
MS3 706 706 1071 1071 1071 1509
382 382 382 909 909 1347
2 2 2 2 2 2
202 281 202 526 526 672
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was used under standard settings [20]. All mass spectra
shown were acquired over a period of approximately
30 s. For fragmentation by collision induced dissocia-
tion (CID) the relative collision energy in the QIT was
set to 40–65% (corresponding to the LCQ software
settings) depending on the charge and/or the chemical
nature of the precursor ions. The precursor ion selection
was carried out with an isolation width of 3 Da.
Results and Discussion
Figure 1 shows the nano-ESI mass spectrum of the total,
neutral fraction of oligosaccharides from human milk in
the negative ion mode; the observed deprotonated
molecules show the major constituents present. In order
to describe their composition out of the well-known
building blocks, a simple nomenclature is introduced.
The composition of human milk oligosaccharides is
described as Lx/y-z, with the core structures: L 
lactose (reducing end); Lac; x number of N-Acetyllac-
tosamine subunits, LacNAc (type I and/or II); and the
residues: y  number of fucoses, Fuc; z  number of
sialic acids, Sia.
For instance, L1/0-0 comprises one lactose as reduc-
ing end and one N-acetyllactosamine unit, and no
fucose or sialic acid residues.
In a preceeding paper [1] it has been demonstrated,
that deprotonated neutral oligosaccharides show con-
secutive C-type fragmentation yielding sequence infor-
mation as well as cross-ring fragments of the “new”
reducing ends which yield information about the link-
age type of internal monosaccharide subunits. CID
mass spectra can be interpreted by reading mass incre-
ments in the mass spectrum “from right to left”.
The molecular ion at m/z 706, representing the dep-
rotonated species of composition L1/0-0 (please refer to
Figure 2) , was subjected to CID-fragmention in order to
address the question whether it is possible to distin-
guish the two possible isomers, LNT ([Gal 13 3
GlcNAc 13 3 Gal 13 4 Glc]) and LNnT ([Gal
13 4 GlcNAc 13 3 Gal 13 4 Glc]), which differ
in the linkage in their terminal LacNAc; whereas the
LacNAc in LNT belongs to the lacto-series (type I, Gal
13 3 GlcNAc), LNnT comprises a terminal LacNAc
of the lacto-neo-series (type II, Gal 13 4 GlcNAc). It is
known that the mixture of neutral oligosaccharides
contains both isomers, however, pooled human milk
contains 0,5– 1,5 g/l LNT whereas the corresponding
isomer LNnT is found in lower amounts (0.1 g/L)
[21].
The MS2 spectrum of the precursor ion at m/z 706 is
shown in Figure 2a; the occurence of m/z 281, 263, and
202 in the MS2 spectrum indicates that both isomers are
present in the mixture. This is confirmed by a MS3
experiment of the fragment ion m/z 382 (Figure 2b).
While LNT produces the characteristic fragment ions of
m/z 202 and 179, the 13 4-linkage of the GlcNAc in
LNnT is reflected by the fragment ions at m/z 281 and
263. As expected, the fragment ions of LNT are ob-
served with stronger signal intensities because the
concentration of this isomer is higher than that of LNnT.
Figure 2c summarizes the fragmentation pathway of
both isomers. For comparison, the observed masses of
fragment ions in MSn experiments of the individual
Figure 1. Nano-electrospray mass spectrum of the total fraction
of neutral oligosaccharides from pooled human milk (negative ion
mode). The ion signals are labeled with the corresponding com-
position Lx/y-z; the signals investigated in MSn experiments are
represented by L1/0-0, L1/1-0 and L2/1-0.
Figure 2. (a) MS2 spectrum of m/z 706 (composition L1/0-0). (b)
MS3 spectrum of the fragment ion at m/z 382 as precursor ion (
m/z 706  m/z 382). (c) Fragmentation pathways for the two
possible isomers with the composition L1/0-0, LNT and LNnT,
present in the mixture. The grey region illustrates the meaning of
the observed fragment ions [R1  (LacNAc  Gal) and R2 
(LacNAc) with LacNAc of the lacto- or lacto-neo-series].
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isomeric structures are summerized in Table 1 (for
detailed discussion and complete structures see [1]).
In the next step the mono-fucosylated compounds of
composition L1/1-0 were inspected, i.e., the deproto-
nated molecules at m/z 852. It is known that four
different isomers of this composition exist in pooled
human milk; these are LNFP I, II, III, and V (the
structures are given in Figure 3b, for detailed discussion
see [1]). For comparison the fragment ions found in MS2
experiments for the individual isomeric glycoforms are
summerized in Figure 3b as well as in Table 1. Figure 3a
shows the MS2 spectrum of the precursor ion m/z 852;
the spectrum shows characteristic signals of LNFP I, II,
and III at m/z 325, 348 and 364, respectively. Magnifica-
tion (20) for m/z 544 reveals that the isomer LNFP V is
present, too.
Whereas the presence of the isomers with the com-
position L1/0-0, LNT, and LNnT, as well the isomers
with the composition L1/1-0, LNFP I, LNFP II, LNFP
III, and LNFP V, is well known for the total fraction of
neutral oligosaccharides from pooled human milk (e.g.,
[21]), only a few complete isomeric structures are
known for larger neutral (and acidic) oligosaccharides.
For testing this method for its application to larger
molecules, an isomeric mixture of molecules with the
composition L2/1-0 ([M  H] m/z 1217) has been
investigated. Again, the total fraction of neutral oligo-
saccharides from pooled human milk was used as
sample. Figure 4 shows the basic structures that may be
Table 2. Isomeric structures
Abbreviation Structures Reference This study
F-LNH I Gal (1 3 4) GlcNAc (1 3 6) [22] Represented by G
Gal (1 3 4) Glc
Fuc (1 3 2) Gal (1 3 3) GlcNAc (1 3 3)
F-LNH II Gal (1 3 4) GlcNAc [(1 3 3) Fuc] (1 3 6) [23] Represented by F
Gal (1 3 4) Glc [27]
Gal (1 3 3) GlcNAc (1 3 3)
F-LNneoH” Fuc 13
Gal (134) GlcNAc (136)
Gal (134) Glc
Gal (134 GlcNAc (133)
[24] Represented by F
and G
F-LNparaH Gal(1 3 3)GlcNAc (1 3 3)Gal (1 3 3) Gal (1 3 4) GlcNac[(1




Gal (1 3 3)GlcNAc[(1 3 4)Fuc] (1 3 3) Gal (1 3 4) GlcNac (1
3 3) Gal (1 3 4) Glc
[27] B
Figure 3. MS2 experiment of m/z 852 as precursor ion (corre-
sponding to the monofucosylated composition L1/1-0).
Figure 4. Possible basic structures of isomers with L2/1-0 as
composition [(a) linear and (b) branched structures]. The number
of possible substructures is indicated above each unit; for further
explanations see text.
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either linear (Figure 4a) or branched (Figure 4b) and
may contain either LacNAc subunits of the lacto- or
lacto-neo-series. Fucosylation may occur either at the
C(3) of the reducing end glucose (Glc) or at each
N-acetyl lactosamin subunit (attached to Gal or Glc-
NAc). The number of possible isomeric substructures is
indicated above each subunit; therefore, for the compo-
sition L2/1-0 twenty different linear and twenty differ-
ent branched isomeric structures are theoretically pos-
sible.
Out of the 40 possible isomers, five isomeric struc-
tures with the composition L2/1-0 have been identified
before. These are F-LNH I [22], F-LNH II [23], “F-
LNneoH” [24] (the fucose position has been determined
to be at one of the branches), and F-para-LNH [25–27]
and another linear structure described in [22]. Their
structures are exhibited in Table 2a.
Figure 5a shows the MS2 spectrum of the precursor
ion at m/z 1217; a mass increment of 164 is not observed.
This indicates that the mixture does not contain a
measurable amount of isomers which contain a fucose
at the reducing-end glucose. Therefore, the possible
isomeric structures 3a and 3b as indicated in Figure 4 of
either linear or branched structures are not present in
this mixture, which leads to the exclusion of the pres-
ence of 8 out of 40 possible isomeric structures.
The mass increments of 60 and 78 Da reflect the
13 4-linked hexose (glucose) of the reducing-end lac-
tose. A loss of this glucose results in m/z 1055; this
fragment ion was chosen for a subsequent MS3 experi-
Figure 5. (a) MS2 spectrum of m/z 1217 (composition L2/1-0). (b)
MS3 spectrum of m/z 1055 as precursor ion ( m/z 1217  1055).
The fragment ions corresponding to linear isomers are indicated
with diamond symbols; those corresponding to branched isomers
are marked with cross symbols (branched isomers). (c) Fragmen-
tation pathway for the possible isomers with the composition
L2/1-0 present in the mixture. Distinct fragmentation channels are
observed for different subgroups of linear isomers (indicated with
white and black diamond symbols) and branched isomeric struc-
tures (marked with white and black cross symbols). Again, the
grey region illustrates the meaning of the observed fragment ions,
with R  (LacNac  LacNAc  Fuc  Gal).
Figure 6. Illustration for the possibility to identify a subgroup of
isomers containing LacNAcs of the lacto-neo-series (13 4-link-
age) out of a complex mixture by mass spectrometry via the
selection of characteristic fragment ions for further collision-
induced dissociation. The identification of isomers containing
LacNAcs of the lacto- series (13 -linkage) is not possible as those
do not produce characteristic cross-ring fragments.
Figure 7. (a) MS3 spectrum of the fragment ion at m/z 792 as
precursor ion ( m/z 1217  792). (b) Fragmentation pathway
leading to the identification of the isomers A, B, and C (see also
text and Figure 9).
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ment (spectrum shown in Figure 5b), since the next
fragmentation will be different for linear or branched
structures. For example, the fragment ion at m/z 893
shows a further elimination of another hexose (galac-
tose, Gal); this means that linear isomers are present in
the mixture (marked with a diamond symbol). Thus,
this fragment ion and the following cross-ring fragment
signals at m/z 792 and 774 belong to the subgroup of
linear isomers as well as the fragment ion at m/z 729.
The observed elimination of LacNAc (with or with-
out additional fucose) moreover indicate the presence
of branched structures in this isomeric mixture (marked
with a cross symbol), those will be discussed later in the
text. The corresponding fragmentation pathway is illus-
trated in Figure 5c.
First, the subgroup of linear isomers was subjected to
further mass spectrometric investigations. The fragment
ion at m/z 792 and 774 are cross-ring fragments of a
13 4-linked GlcNAc, indicating the presence of a sub-
group of isomers present in the mixture (symbolized by
white diamond symbol), whereas 729 (elimination of
fucose) proves the presence of second series of compo-
nents with a 13 3-fucosylation (preventing cross-ring
fragment ions); in the following, the latter series is
symbolized by a black diamond symbol.
As 13 4-linked N-acetyl-glucosamins (GlcNAc)
produce characteristic cross-ring fragments, it can be
determined unambiguously that the mixture contains
isomers with a 13 4-linkage (lacto-neo-series) within
this LacNAc (for further MSn studies, selection of these
cross-ring fragments is required). But 13 3-linked N-
acetyl-glucosamines do not produce characteristic
cross-ring fragment ions; therefore, mass spectrometric
identification of a subgroup of linear isomers contain-
ing LacNAcs of the lacto-series (13 3-linkage) out of a
complex mixture is not possible, as no characteristic
fragment ion may be selected for further collision-
induced dissociation (as illustrated in Figure 6).
In a first step, the precursor ion at m/z 792 was
chosen for a further CID experiment; the MS3 spectrum
(Figure 7a) shows characteristic fragment ions at m/z
325, 348, and 364 indicating that the last ( non-
reducing) LacNac-subunit exhibits the fucosylation pat-
tern of LNFP I, II, or III, respectively (see above). Figure
7b illustrates the fragmentation pathway leading to the
identification of the isomers A, B, and C (see also Figure
9).
In a next step, the selection of m/z 729 defined by the
elimination of reducing lactose and a fucose (either in
the MS3 or MS4) leads to a subgroup of isomers exhib-
iting the fucosylation at the internal LacNAc in a 
13 3-linkage to GlcNAc. CID experiments with this
precursor ion show a consecutive loss of this GlcNAc
(185 Da to form m/z 544, see Figure 8a). Fragment ions
at m/z 202, 281, and 263 reveal the presence of two
Figure 8. (a) MS3 spectrum of the fragment ion at m/z 729 as
precursor ion ( m/z 1217 m/z 729). (b) Fragmentation pathway
leading to the identification of isomers D and E (see also text and
Figure 9).
Figure 9. Five linear isomers with the composition L2/1-0 found
in the mixture. The grey attributions indicate that there may be
also isomers present in the mixture which exhibit other linkages
within the internal LacNAc (see text).
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isomers, D and E, which contain a non-reducing Lac-
NAc of both the lacto-series and the lacto-neo-series, as
indicated in Figure 8b.
Whereas the presence of an internal LacNAc of the
lacto-neo series with a 13 3-linked fucose is thus clearly
shown, it cannot be determined unambiguously whether
this internal LacNAc is also present in the lacto form with
a 13 4-linked fucose, since this would result in the direct
loss of both monosaccharide units to form m/z 544 (loss of
349 Da). Figure 9 summarizes the different linear isomers
A–E determined to be present in the mixture. The grey
attributions in the structures a–e indicate that there may
be also isomers present in the mixture, which exhibit other
linkages within the internal LacNAc, such as  13 3 in
the Structures A, B, and C (internal LacNAc corresponds
to the lacto-series) and  13 4 in Structures D and E
(internal Lac-neo-Nac, therefore the fucose is  13 4-
linked to the GlcNAc).
As derived above, also branched structures are
present in the mixture. In principle, two different basic
structures are observed (Figure 11), as indicated by the
fragment ions at m/z 672 and 526 representing the
elimination of the 13 3-branch (for detailed discussion
see [1]). The latter results from a elimination of a
LacNAc subunit, which contains a fucose, whereas m/z
672 is produced by the loss of a LacNAc; in this case, the
fucose is linked to the 13 6-branch. Both losses result in
mass increments of 383 and 529 Da (from m/z 1055),
respectively. As discussed in detail in [1], these losses
occur because of the elimination of the 13 3-branch; a
further structural analysis of this branch becomes thereby
impossible.
In the next step the linkage in the remaining “tri- or
tetrasaccharide” has to be determined. MS3 experiments
of fragment ion m/z 672 (Figure 10a) and m/z 526 (Figure
10b) prove the presence of structures F and G, as
illustrated in Figure 10c. The presence of m/z 364 in the
MS3 spectrum of m/z 672 reveals that the fucose is
linked to the GlcNAc of a Lac-neo-NAc subunit (like in
LNFP III, compare to Table 1). Structure F (white cross)
represents two possible isomers, where the LacNAc
subunit belongs either to the lacto-series (13 3-linkage
of galactose and N-actyl-lactosamin) or to the lacto-neo-
series (13 4-linkage).
Figure 10b shows the MS3 spectrum of the precursor
ion m/z 526; the presence of fragment ions at m/z 281
and 263 demonstrates the 13 4-linkage of this LacNAc
subunit (Lac-neo-NAc), whereas the absence of m/z 202
proves that no isomer with a LacNAc of the lacto-series
in this region is present in the mixture. Therefore,
structure G represents four different possible isomers:
Either the fucose may be linked to the non-reducing
galactose or it may also be linked to a GlcNAc in a
13 4-linkage (LacNAc) or in a 13 3-linkage (Lac-neo-
NAc). Figure 10c summerizes the branched isomeric
structures corresponding to the composition of L2/1-0
indicating the uncertainties remaining within the 13 3
branch (marked in black).
Figure 10. MS3 experiments of branched isomers with the com-
position L2/1-0. (a) MS3 spectrum of the fragment ion at m/z 672
as precursor ion. (b) MS3 spectrum of the fragment ion at m/z 526
as precursor ion. (c) Fragmentation pathway of the branched
isomers with the fucose linked to the 13 6-branches (F) or the
13 3-branches (G).
Figure 11. Branched isomers with the composition L2/1-0 found
in the mixture. The grey fields indicate LacNac subunits which
cannot be characterized in detail. For structure F there are two
possible isomers, whereas structure G may represent four isomers
(see text).
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Conclusion
It could be demonstrated that MSn experiments of depro-
tonated neutral oligosaccharides can be applied for struc-
tural analysis of oligosaccharides out of complex isomeric
mixtures. Linear, fucosylated, and branched structures
can be differentiated by making use of specific fragmen-
tation channels which result in a separation into sub-
groups of the present isomeric mixture. For the first time,
the presence of both linear and branched structures of
neutral oligosaccharides, out of complex isomeric mix-
tures, has been revealed by mass spectrometry. Problems
arise for internal LacNAcs that do not produce specific
fragment ions for either lacto-series or for GlcNAc-fuco-
sylated lacto-neo constituents. Moreover, structure eluci-
dation of 13 3-branches of branched structures is not
possible due to its elimination.
Out of 40 possible isomers with the composition
L2/1-0, 24 isomers could be excluded to be present in
the mixture. These are those eight with the fucose
linked to the reducing glucose (Figure 4, 3a and 3b),
four linear isomers that could contain the fucose at the
galactose of the internal LacNac (Figure 4, 1a and 2a),
eight branched structures that have the fucose linked to
the terminal galactose and four branched isomers that
have a LacNAc-subunit of the type II (13 3-linkage)
in their 13 3-branch (Figure 4, 1b and 2b).
In total, five isomers (A–E) could be determined
completely based on their specific fragment ions; three
of those have never been described before (A, C, and E,
which are marked with an asterix in Figure 9). Isomeric
linear structures that exhibit the fucose at the terminal
galactose (e.g., A) and such based on paraLNneoH [22]
(e.g., C and E) have not been reported before. Five more
isomers (a–e) could not be exluded to be present in the
mixture. Structure F and G may represent two and four
isomeric structures, respectively, of which two have
been described before (see Table 2).
All these experiments were carried out with pooled
neutral human milk oligosaccharides which represent a
very complex mixture. Therefore, the tools developed
lend themselves to be applied to individual human milk
oligosaccharides in future investigations since based on
the individual enzyme equipment an informative dif-
ferentiation and selective expression of oligosaccharide
isomers is to be expected.
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